Bone repair
![BioSenic's stock declines as it discontinues bone-repair treatment](https://pharmtales.com/wp-content/uploads/2023/06/BioSenics-stock-declines-as-it-discontinues-bone-repair-treatment.jpg)
BioSenic’s stock declines as it discontinues bone-repair treatment
SG Tylor
Source – BioSenic A Phase II b study of ALLOB, a stem cell-derived treatment intended to quicken bone fracture repair, ...
Source – BioSenic A Phase II b study of ALLOB, a stem cell-derived treatment intended to quicken bone fracture repair, ...